FOLLOW US: @theinsaneapp
Synchron, a brain-computer interface tech startup, announced Thursday that it had raised $75 million in a new round of funding.
Twitter | Insatagram | Facebook
FOLLOW US: @theinsaneapp
This included cash injections from Gates Frontier and Bezos Expeditions.
Twitter | Insatagram | Facebook
FOLLOW US: @theinsaneapp
Although Synchron is often viewed as a smaller, less-capitalized competitor to Elon Musk’s Neuralink (which many consider it), it is moving ahead with its plans.
Twitter | Insatagram | Facebook
FOLLOW US: @theinsaneapp
Brain-computer interfaces (BCIs), a science that traces back to the 1960s, are maturing quickly.
Twitter | Insatagram | Facebook
FOLLOW US: @theinsaneapp
Companies are trying to convince paralyzed patients that their products can be used as a means of obtaining affordable healthcare.
Twitter | Insatagram | Facebook
FOLLOW US: @theinsaneapp
Synchron's unique feature is its ability to be inserted via the jugular vein with a stent rather than literal brain surgery.
Twitter | Insatagram | Facebook
FOLLOW US: @theinsaneapp
The company understood the meaning of the expression "go for it jugular."
Twitter | Insatagram | Facebook
FOLLOW US: @theinsaneapp
The stentrode is implanted in the brain of a person and allows them to communicate with computers by using their mind.
Twitter | Insatagram | Facebook
FOLLOW US: @theinsaneapp
Bezos and Gates weren't the only Silicon Valley investors in Synchron. Earlier this year, Max Hodak, Neuralink's ex-president, invested in the company.
Twitter | Insatagram | Facebook